GlassScriptPhysician profile
Adeela R Ahsan
NPI 1932103595
$1,809.66
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $771 · 2021: $250 · 2022: $23.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $314.57 | 2019-2021 | |
| Amgen INC. | $213.75 | 2019-2021 | |
| Abbvie INC. | $155.53 | 2019-2021 | |
| Novo Nordisk INC | $122.15 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $115.16 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $103.46 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.42 | 2019-2020 | |
| Janssen Biotech, INC. | $83.72 | 2020 | |
| W. L. Gore & Associates, INC. | $78.95 | 2019 | |
| Ibsa Pharma INC. | $78.77 | 2019-2020 | |
| Amarin Pharma, INC. | $76.13 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $56.79 | 2019 | |
| Merck Sharp & Dohme LLC | $52.72 | 2020-2021 | |
| Radius Health, INC. | $46.30 | 2020 | |
| Ethicon INC. | $23.27 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $22.26 | 2021 | |
| Abbott Laboratories | $21.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.86 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.94 | 2021 | |
| Scilex Pharmaceuticals INC. | $17.60 | 2019 | |
| Allergan, INC. | $17.53 | 2020 | |
| Shire North American Group INC | $15.99 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeela Ahsan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.